Condensed Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Cost and operating expenses:
Cost of product revenue	$ 707	$ 0	$ 707	$ 0
Research and development	92,106	32,182	132,316	60,010
Selling, general and administrative	30,186	17,072	56,743	35,099
Total cost and operating expenses	122,999	49,254	189,766	95,109
Loss from operations	(114,807)	(49,254)	(181,574)	(95,109)
Non-operating income (expense):
Gain from sale of priority review voucher	108,000	0	108,000	0
Investment income, net	3,962	3,406	8,327	6,872
Other expense, net	(10)	(15)	(20)	(19)
Total non-operating income, net	111,952	3,391	116,307	6,853
Loss before income taxes	(2,855)	(45,863)	(65,267)	(88,256)
Income tax expense	(1,552)	0	(1,552)	0
Net loss	$ (4,407)	$ (45,863)	$ (66,819)	$ (88,256)
Net loss per share, basic	$ (0.05)	$ (0.61)	$ (0.77)	$ (1.2)
Net loss per share, diluted	$ (0.05)	$ (0.61)	$ (0.77)	$ (1.2)
Weighted-average number of common shares used in computing net loss per share, basic	87,121,310	74,964,878	86,864,545	73,478,567
Weighted-average number of common shares used in computing net loss per share, diluted	87,121,310	74,964,878	86,864,545	73,478,567
Product [Member]
Revenue:
Total revenue, net	$ 8,192	$ 0	$ 8,192	$ 0